GGrantIndex
Sort

53,477 grants matching addiction

Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology

$721,027
Laura M Bohn · Scripps Florida · R01 · FY2016 · DA

Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder

$721,027
Joseph T Sakai · University Of Colorado Denver · UG3 · FY2022 · DA

Advancing the Use of Oral Fluid to Monitor Therapeutic and Illicit Drugs in Outpatient Clinical and Field Settings

$720,974
Stephen Magura · Western Michigan University · R01 · FY2020 · DA

Making Better Decisions: Policy Modeling for AIDS and Drug Abuse

$720,966
Douglas K Owens · Stanford University · R37 · FY2019 · DA

Neurophysiology underlying neural representations of value

$720,901
C. Daniel Salzman · Columbia University Health Sciences · R01 · FY2019 · MH

Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain Management

$720,780
Nina Cooperman · Rbhs-Robert Wood Johnson Medical School · R33 · FY2020 · AT

Basic Dopamine Transporter Mechanisms Of Cocaine

$720,689
Jonathan L Katz · National Institute On Drug Abuse · ZIA · FY2011 · DA

Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety

$720,687
Shanna Babalonis · University Of Kentucky · R01 · FY2022 · DA

INROADS-A: Intersecting Research on Addiction and Disability Services - Alcohol

$720,661
Sharon Reif · Brandeis University · R01 · FY2023 · AA

Motivational Interviewing: An Experiential Online Training Tool

$720,603
Jeffrey Olivet · C4 Innovations, Llc · R44 · FY2015 · MH

Cortico-striatal plasticity in the transition to chronic pain

$720,571
Apkar Vania Apkarian · Northwestern University At Chicago · R01 · FY2014 · DE

ANALYSIS OF TOBACCO DEPOSITIONS AND TRIAL TESTIMONY

$720,420
Michigan Public Health Institute · R01 · FY2001 · CA

Acupuncture in the Emergency Department for Pain Management: A BraveNet Multi-Center Feasibility Study

$720,401
Jeffery A Dusek · Case Western Reserve University · U01 · FY2020 · AT

Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population

$720,367
E. Jennifer Edelman · Yale University · R01 · FY2023 · AA

Career Enhancement Core

$720,266
Alison Breland · Virginia Commonwealth University · U54 · FY2021 · DA

Endocannabinoid brain mechanisms and addiction

$720,193
Eliot Gardner · National Institute On Drug Abuse · ZIA · FY2020 · DA

Evaluation of Dialectical Behavior Therapy (DBT)

$720,018
University Of Washington · R01 · FY2004 · DA

Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse

$719,921
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2020 · DA

Social influences on choices in adolescent substance use

$719,789
Brooks King-Casas · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · DA

Project 3: Adolescent smoking: Vulnerability to Tobacco Use and Market p265-296

$719,765
Jonathan M. Samet · University Of Southern California · P50 · FY2014 · CA

Alcohol consumption, contexts, and consequences across the transition to legal drinking: A longitudinal EMA burst design

$719,749
Timothy J Trull · University Of Missouri-Columbia · R01 · FY2025 · AA

Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk

$719,596
Aaron D Fox · Albert Einstein College Of Medicine · R01 · FY2020 · DA

Component 2: Administrative Core

$719,549
Robert O. Messing · Ernest Gallo Clinic And Research Center · P50 · FY2011 · AA

Addictions treatment organizational response to COVID-19: impact on disparities in quality of care

$719,541
Charles J Neighbors · New York University School Of Medicine · R01 · FY2024 · DA

Establishing an Evidence Base to Increase the Utility of Urine Drug Testing in Opioid Use Disorder Treatment.

$719,523
Brendan K Saloner · Johns Hopkins University · R01 · FY2024 · DA